Dermal Radiomics: a new approach for computer-aided melanoma screening system

Skin cancer is the most common form of cancer in North America, and melanoma is the most dangerous type of skin cancer. Melanoma originates from melanocytes in the epidermis and has a high tendency to develop away from the skin surface and cause metastasis through the bloodstream. Early diagnosis is known to help improve survival rates. Under the current diagnosis, the initial examination of the potential melanoma patient is done via naked eye screening or standard photographic images of the lesion. From this, the accuracy of diagnosis varies depending on the expertise of the clinician. Radiomics is a recent cancer diagnostic tool that centers around the high throughput extraction of quantitative and mineable imaging features from medical images to identify tumor phenotypes. Radiomics focuses on optimizing a large number of features through computational approaches to develop a decision support system for improving individualized treatment selection and monitoring. While radiomics has shown great promise for screening and analyzing di erent forms of cancer such as lung cancer and prostate cancer, to the best of our knowledge, radiomics has not been previously adopted for skin cancer, especially melanoma. This work presents a dermal radiomics framework, which is a novel computer-aided melanoma diagnosis. While most computer-aided melanoma screening systems follow the conventional diagnostic scheme, the proposed work utilizes the physiological biomarker information. To extract physiological biomarkers, non-linear random forest inverse light-skin interaction model is proposed. The construction of dermal radiomics sequence is followed using the extracted physiological biomarkers, and the dermal radiomics framework for melanoma is completed by constructing diagnostic decision system based on random forest classi cation algorithm

Automatic Detection of Critical Dermoscopy Features for Malignant Melanoma Diagnosis

Improved methods for computer-aided analysis of identifying features of skin lesions from digital images of the lesions are provided. Improved preprocessing of the image that 1) eliminates artifacts that occlude or distort skin lesion features and 2) identifies groups of pixels within the skin lesion that represent features and/or facilitate the quantification of features are provided including improved digital hair removal algorithms. Improved methods for analyzing lesion features are also provided

Towards an Effective Imaging-Based Decision Support System for Skin Cancer

The usage of expert systems to aid in medical decisions has been employed since 1980s in distinct ap plications. With the high demands of medical care and limited human resources, these technologies are required more than ever. Skin cancer has been one of the pathologies with higher growth, which suf fers from lack of dermatology experts in most of the affected geographical areas. A permanent record of examination that can be further analyzed are medical imaging modalities. Most of these modalities were also assessed along with machine learning classification methods. It is the aim of this research to provide background information about skin cancer types, medical imaging modalities, data mining and machine learning methods, and their application on skin cancer imaging, as well as the disclosure of a proposal of a multi-imaging modality decision support system for skin cancer diagnosis and treatment assessment based in the most recent available technology. This is expected to be a reference for further implementation of imaging-based clinical support systems.info:eu-repo/semantics/publishedVersio

Cardiovascular/Stroke Risk Stratification in Diabetic Foot Infection Patients Using Deep Learning-Based Artificial Intelligence: An Investigative Study

A diabetic foot infection (DFI) is among the most serious, incurable, and costly to treat conditions. The presence of a DFI renders machine learning (ML) systems extremely nonlinear, posing difficulties in CVD/stroke risk stratification. In addition, there is a limited number of well-explained ML paradigms due to comorbidity, sample size limits, and weak scientific and clinical validation methodologies. Deep neural networks (DNN) are potent machines for learning that generalize nonlinear situations. The objective of this article is to propose a novel investigation of deep learning (DL) solutions for predicting CVD/stroke risk in DFI patients. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) search strategy was used for the selection of 207 studies. We hypothesize that a DFI is responsible for increased morbidity and mortality due to the worsening of atherosclerotic disease and affecting coronary artery disease (CAD). Since surrogate biomarkers for CAD, such as carotid artery disease, can be used for monitoring CVD, we can thus use a DL-based model, namely, Long Short-Term Memory (LSTM) and Recurrent Neural Networks (RNN) for CVD/stroke risk prediction in DFI patients, which combines covariates such as office and laboratory-based biomarkers, carotid ultrasound image phenotype (CUSIP) lesions, along with the DFI severity. We confirmed the viability of CVD/stroke risk stratification in the DFI patients. Strong designs were found in the research of the DL architectures for CVD/stroke risk stratification. Finally, we analyzed the AI bias and proposed strategies for the early diagnosis of CVD/stroke in DFI patients. Since DFI patients have an aggressive atherosclerotic disease, leading to prominent CVD/stroke risk, we, therefore, conclude that the DL paradigm is very effective for predicting the risk of CVD/stroke in DFI patients

Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine

Radiogenomics, a combination of “Radiomics” and “Genomics,” using Artificial Intelligence (AI) has recently emerged as the state-of-the-art science in precision medicine, especially in oncology care. Radiogenomics syndicates large-scale quantifiable data extracted from radiological medical images enveloped with personalized genomic phenotypes. It fabricates a prediction model through various AI methods to stratify the risk of patients, monitor therapeutic approaches, and assess clinical outcomes. It has recently shown tremendous achievements in prognosis, treatment planning, survival prediction, heterogeneity analysis, reoccurrence, and progression-free survival for human cancer study. Although AI has shown immense performance in oncology care in various clinical aspects, it has several challenges and limitations. The proposed review provides an overview of radiogenomics with the viewpoints on the role of AI in terms of its promises for computa-tional as well as oncological aspects and offers achievements and opportunities in the era of precision medicine. The review also presents various recommendations to diminish these obstacles

Artificial Intelligence Techniques in Medical Imaging: A Systematic Review

This scientific review presents a comprehensive overview of medical imaging modalities and their diverse applications in artificial intelligence (AI)-based disease classification and segmentation. The paper begins by explaining the fundamental concepts of AI, machine learning (ML), and deep learning (DL). It provides a summary of their different types to establish a solid foundation for the subsequent analysis. The prmary focus of this study is to conduct a systematic review of research articles that examine disease classification and segmentation in different anatomical regions using AI methodologies. The analysis includes a thorough examination of the results reported in each article, extracting important insights and identifying emerging trends. Moreover, the paper critically discusses the challenges encountered during these studies, including issues related to data availability and quality, model generalization, and interpretability. The aim is to provide guidance for optimizing technique selection. The analysis highlights the prominence of hybrid approaches, which seamlessly integrate ML and DL techniques, in achieving effective and relevant results across various disease types. The promising potential of these hybrid models opens up new opportunities for future research in the field of medical diagnosis. Additionally, addressing the challenges posed by the limited availability of annotated medical images through the incorporation of medical image synthesis and transfer learning techniques is identified as a crucial focus for future research efforts

Advanced Computational Methods for Oncological Image Analysis

[Cancer is the second most common cause of death worldwide and encompasses highly variable clinical and biological scenarios. Some of the current clinical challenges are (i) early diagnosis of the disease and (ii) precision medicine, which allows for treatments targeted to specific clinical cases. The ultimate goal is to optimize the clinical workflow by combining accurate diagnosis with the most suitable therapies. Toward this, large-scale machine learning research can define associations among clinical, imaging, and multi-omics studies, making it possible to provide reliable diagnostic and prognostic biomarkers for precision oncology. Such reliable computer-assisted methods (i.e., artificial intelligence) together with clinicians’ unique knowledge can be used to properly handle typical issues in evaluation/quantification procedures (i.e., operator dependence and time-consuming tasks). These technical advances can significantly improve result repeatability in disease diagnosis and guide toward appropriate cancer care. Indeed, the need to apply machine learning and computational intelligence techniques has steadily increased to effectively perform image processing operations—such as segmentation, co-registration, classification, and dimensionality reduction—and multi-omics data integration.